Pharma & Healthcare

Global Cholinergic Drugs Market Research Report 2024

Cholinergic drug, any of various drugs that inhibit, enhance, or mimic the action of the neurotransmitter acetylcholine, the primary transmitter of nerve impulses within the parasympathetic nervous system.
The global Cholinergic Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Cholinergic Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cholinergic Drugs.
Report Scope
The Cholinergic Drugs market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Cholinergic Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cholinergic Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Allergan
Novartis AG
Eisai Co
H Lundbeck A/S
Daiichi Sankyo Company Limited
Ono Pharmaceutical Co Ltd
Johnson & Johnson
Segment by Type
Powder
Tablet
Capsule
Segment by Application
Hospital Pharmacy
Retail Pharmacy
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cholinergic Drugs companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cholinergic Drugs Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Powder
1.2.3 Tablet
1.2.4 Capsule
1.3 Market by Application
1.3.1 Global Cholinergic Drugs Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cholinergic Drugs Market Perspective (2019-2030)
2.2 Cholinergic Drugs Growth Trends by Region
2.2.1 Global Cholinergic Drugs Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Cholinergic Drugs Historic Market Size by Region (2019-2024)
2.2.3 Cholinergic Drugs Forecasted Market Size by Region (2025-2030)
2.3 Cholinergic Drugs Market Dynamics
2.3.1 Cholinergic Drugs Industry Trends
2.3.2 Cholinergic Drugs Market Drivers
2.3.3 Cholinergic Drugs Market Challenges
2.3.4 Cholinergic Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cholinergic Drugs Players by Revenue
3.1.1 Global Top Cholinergic Drugs Players by Revenue (2019-2024)
3.1.2 Global Cholinergic Drugs Revenue Market Share by Players (2019-2024)
3.2 Global Cholinergic Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Cholinergic Drugs Revenue
3.4 Global Cholinergic Drugs Market Concentration Ratio
3.4.1 Global Cholinergic Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cholinergic Drugs Revenue in 2023
3.5 Cholinergic Drugs Key Players Head office and Area Served
3.6 Key Players Cholinergic Drugs Product Solution and Service
3.7 Date of Enter into Cholinergic Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Cholinergic Drugs Breakdown Data by Type
4.1 Global Cholinergic Drugs Historic Market Size by Type (2019-2024)
4.2 Global Cholinergic Drugs Forecasted Market Size by Type (2025-2030)
5 Cholinergic Drugs Breakdown Data by Application
5.1 Global Cholinergic Drugs Historic Market Size by Application (2019-2024)
5.2 Global Cholinergic Drugs Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Cholinergic Drugs Market Size (2019-2030)
6.2 North America Cholinergic Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Cholinergic Drugs Market Size by Country (2019-2024)
6.4 North America Cholinergic Drugs Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Cholinergic Drugs Market Size (2019-2030)
7.2 Europe Cholinergic Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Cholinergic Drugs Market Size by Country (2019-2024)
7.4 Europe Cholinergic Drugs Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cholinergic Drugs Market Size (2019-2030)
8.2 Asia-Pacific Cholinergic Drugs Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Cholinergic Drugs Market Size by Region (2019-2024)
8.4 Asia-Pacific Cholinergic Drugs Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Cholinergic Drugs Market Size (2019-2030)
9.2 Latin America Cholinergic Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Cholinergic Drugs Market Size by Country (2019-2024)
9.4 Latin America Cholinergic Drugs Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cholinergic Drugs Market Size (2019-2030)
10.2 Middle East & Africa Cholinergic Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Cholinergic Drugs Market Size by Country (2019-2024)
10.4 Middle East & Africa Cholinergic Drugs Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Allergan
11.1.1 Allergan Company Detail
11.1.2 Allergan Business Overview
11.1.3 Allergan Cholinergic Drugs Introduction
11.1.4 Allergan Revenue in Cholinergic Drugs Business (2019-2024)
11.1.5 Allergan Recent Development
11.2 Novartis AG
11.2.1 Novartis AG Company Detail
11.2.2 Novartis AG Business Overview
11.2.3 Novartis AG Cholinergic Drugs Introduction
11.2.4 Novartis AG Revenue in Cholinergic Drugs Business (2019-2024)
11.2.5 Novartis AG Recent Development
11.3 Eisai Co
11.3.1 Eisai Co Company Detail
11.3.2 Eisai Co Business Overview
11.3.3 Eisai Co Cholinergic Drugs Introduction
11.3.4 Eisai Co Revenue in Cholinergic Drugs Business (2019-2024)
11.3.5 Eisai Co Recent Development
11.4 H Lundbeck A/S
11.4.1 H Lundbeck A/S Company Detail
11.4.2 H Lundbeck A/S Business Overview
11.4.3 H Lundbeck A/S Cholinergic Drugs Introduction
11.4.4 H Lundbeck A/S Revenue in Cholinergic Drugs Business (2019-2024)
11.4.5 H Lundbeck A/S Recent Development
11.5 Daiichi Sankyo Company Limited
11.5.1 Daiichi Sankyo Company Limited Company Detail
11.5.2 Daiichi Sankyo Company Limited Business Overview
11.5.3 Daiichi Sankyo Company Limited Cholinergic Drugs Introduction
11.5.4 Daiichi Sankyo Company Limited Revenue in Cholinergic Drugs Business (2019-2024)
11.5.5 Daiichi Sankyo Company Limited Recent Development
11.6 Ono Pharmaceutical Co Ltd
11.6.1 Ono Pharmaceutical Co Ltd Company Detail
11.6.2 Ono Pharmaceutical Co Ltd Business Overview
11.6.3 Ono Pharmaceutical Co Ltd Cholinergic Drugs Introduction
11.6.4 Ono Pharmaceutical Co Ltd Revenue in Cholinergic Drugs Business (2019-2024)
11.6.5 Ono Pharmaceutical Co Ltd Recent Development
11.7 Johnson & Johnson
11.7.1 Johnson & Johnson Company Detail
11.7.2 Johnson & Johnson Business Overview
11.7.3 Johnson & Johnson Cholinergic Drugs Introduction
11.7.4 Johnson & Johnson Revenue in Cholinergic Drugs Business (2019-2024)
11.7.5 Johnson & Johnson Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Cholinergic Drugs Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Powder
Table 3. Key Players of Tablet
Table 4. Key Players of Capsule
Table 5. Global Cholinergic Drugs Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Cholinergic Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Cholinergic Drugs Market Size by Region (2019-2024) & (US$ Million)
Table 8. Global Cholinergic Drugs Market Share by Region (2019-2024)
Table 9. Global Cholinergic Drugs Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 10. Global Cholinergic Drugs Market Share by Region (2025-2030)
Table 11. Cholinergic Drugs Market Trends
Table 12. Cholinergic Drugs Market Drivers
Table 13. Cholinergic Drugs Market Challenges
Table 14. Cholinergic Drugs Market Restraints
Table 15. Global Cholinergic Drugs Revenue by Players (2019-2024) & (US$ Million)
Table 16. Global Cholinergic Drugs Market Share by Players (2019-2024)
Table 17. Global Top Cholinergic Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cholinergic Drugs as of 2023)
Table 18. Ranking of Global Top Cholinergic Drugs Companies by Revenue (US$ Million) in 2023
Table 19. Global 5 Largest Players Market Share by Cholinergic Drugs Revenue (CR5 and HHI) & (2019-2024)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Cholinergic Drugs Product Solution and Service
Table 22. Date of Enter into Cholinergic Drugs Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Cholinergic Drugs Market Size by Type (2019-2024) & (US$ Million)
Table 25. Global Cholinergic Drugs Revenue Market Share by Type (2019-2024)
Table 26. Global Cholinergic Drugs Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 27. Global Cholinergic Drugs Revenue Market Share by Type (2025-2030)
Table 28. Global Cholinergic Drugs Market Size by Application (2019-2024) & (US$ Million)
Table 29. Global Cholinergic Drugs Revenue Market Share by Application (2019-2024)
Table 30. Global Cholinergic Drugs Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 31. Global Cholinergic Drugs Revenue Market Share by Application (2025-2030)
Table 32. North America Cholinergic Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 33. North America Cholinergic Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 34. North America Cholinergic Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 35. Europe Cholinergic Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. Europe Cholinergic Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 37. Europe Cholinergic Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 38. Asia-Pacific Cholinergic Drugs Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 39. Asia-Pacific Cholinergic Drugs Market Size by Region (2019-2024) & (US$ Million)
Table 40. Asia-Pacific Cholinergic Drugs Market Size by Region (2025-2030) & (US$ Million)
Table 41. Latin America Cholinergic Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 42. Latin America Cholinergic Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 43. Latin America Cholinergic Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 44. Middle East & Africa Cholinergic Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Middle East & Africa Cholinergic Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 46. Middle East & Africa Cholinergic Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 47. Allergan Company Detail
Table 48. Allergan Business Overview
Table 49. Allergan Cholinergic Drugs Product
Table 50. Allergan Revenue in Cholinergic Drugs Business (2019-2024) & (US$ Million)
Table 51. Allergan Recent Development
Table 52. Novartis AG Company Detail
Table 53. Novartis AG Business Overview
Table 54. Novartis AG Cholinergic Drugs Product
Table 55. Novartis AG Revenue in Cholinergic Drugs Business (2019-2024) & (US$ Million)
Table 56. Novartis AG Recent Development
Table 57. Eisai Co Company Detail
Table 58. Eisai Co Business Overview
Table 59. Eisai Co Cholinergic Drugs Product
Table 60. Eisai Co Revenue in Cholinergic Drugs Business (2019-2024) & (US$ Million)
Table 61. Eisai Co Recent Development
Table 62. H Lundbeck A/S Company Detail
Table 63. H Lundbeck A/S Business Overview
Table 64. H Lundbeck A/S Cholinergic Drugs Product
Table 65. H Lundbeck A/S Revenue in Cholinergic Drugs Business (2019-2024) & (US$ Million)
Table 66. H Lundbeck A/S Recent Development
Table 67. Daiichi Sankyo Company Limited Company Detail
Table 68. Daiichi Sankyo Company Limited Business Overview
Table 69. Daiichi Sankyo Company Limited Cholinergic Drugs Product
Table 70. Daiichi Sankyo Company Limited Revenue in Cholinergic Drugs Business (2019-2024) & (US$ Million)
Table 71. Daiichi Sankyo Company Limited Recent Development
Table 72. Ono Pharmaceutical Co Ltd Company Detail
Table 73. Ono Pharmaceutical Co Ltd Business Overview
Table 74. Ono Pharmaceutical Co Ltd Cholinergic Drugs Product
Table 75. Ono Pharmaceutical Co Ltd Revenue in Cholinergic Drugs Business (2019-2024) & (US$ Million)
Table 76. Ono Pharmaceutical Co Ltd Recent Development
Table 77. Johnson & Johnson Company Detail
Table 78. Johnson & Johnson Business Overview
Table 79. Johnson & Johnson Cholinergic Drugs Product
Table 80. Johnson & Johnson Revenue in Cholinergic Drugs Business (2019-2024) & (US$ Million)
Table 81. Johnson & Johnson Recent Development
Table 82. Research Programs/Design for This Report
Table 83. Key Data Information from Secondary Sources
Table 84. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Cholinergic Drugs Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Cholinergic Drugs Market Share by Type: 2023 VS 2030
Figure 3. Powder Features
Figure 4. Tablet Features
Figure 5. Capsule Features
Figure 6. Global Cholinergic Drugs Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Cholinergic Drugs Market Share by Application: 2023 VS 2030
Figure 8. Hospital Pharmacy Case Studies
Figure 9. Retail Pharmacy Case Studies
Figure 10. Cholinergic Drugs Report Years Considered
Figure 11. Global Cholinergic Drugs Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 12. Global Cholinergic Drugs Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Cholinergic Drugs Market Share by Region: 2023 VS 2030
Figure 14. Global Cholinergic Drugs Market Share by Players in 2023
Figure 15. Global Top Cholinergic Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cholinergic Drugs as of 2023)
Figure 16. The Top 10 and 5 Players Market Share by Cholinergic Drugs Revenue in 2023
Figure 17. North America Cholinergic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 18. North America Cholinergic Drugs Market Share by Country (2019-2030)
Figure 19. United States Cholinergic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. Canada Cholinergic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Europe Cholinergic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Cholinergic Drugs Market Share by Country (2019-2030)
Figure 23. Germany Cholinergic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. France Cholinergic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. U.K. Cholinergic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Italy Cholinergic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Russia Cholinergic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Nordic Countries Cholinergic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Asia-Pacific Cholinergic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Cholinergic Drugs Market Share by Region (2019-2030)
Figure 31. China Cholinergic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Japan Cholinergic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. South Korea Cholinergic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Southeast Asia Cholinergic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. India Cholinergic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Australia Cholinergic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Latin America Cholinergic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Cholinergic Drugs Market Share by Country (2019-2030)
Figure 39. Mexico Cholinergic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Brazil Cholinergic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Middle East & Africa Cholinergic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Cholinergic Drugs Market Share by Country (2019-2030)
Figure 43. Turkey Cholinergic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Saudi Arabia Cholinergic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Allergan Revenue Growth Rate in Cholinergic Drugs Business (2019-2024)
Figure 46. Novartis AG Revenue Growth Rate in Cholinergic Drugs Business (2019-2024)
Figure 47. Eisai Co Revenue Growth Rate in Cholinergic Drugs Business (2019-2024)
Figure 48. H Lundbeck A/S Revenue Growth Rate in Cholinergic Drugs Business (2019-2024)
Figure 49. Daiichi Sankyo Company Limited Revenue Growth Rate in Cholinergic Drugs Business (2019-2024)
Figure 50. Ono Pharmaceutical Co Ltd Revenue Growth Rate in Cholinergic Drugs Business (2019-2024)
Figure 51. Johnson & Johnson Revenue Growth Rate in Cholinergic Drugs Business (2019-2024)
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies